Biohaven Pharmaceutical Holding Co Ltd.(BHVN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BHVN Biohaven Pharmaceutical Holding Co Ltd.

Post-Mkt 05-18 17:50:01 EDT

8.49

-0.27

-3.08%

盘后8.49

+0.000.00%

16:10 EDT

High8.84	Low8.43	Vol2.11M
Open8.74	D1 Closing8.76	Amplitude4.68%
Mkt Cap1.28B	Tradable Cap1.05B	Total Shares150.42M
T/O18.05M	T/O Rate1.70%	Tradable Shares124.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BHVN","market":"US","secType":"STK","nameCN":"Biohaven Pharmaceutical Holding Co Ltd.","latestPrice":8.49,"timestamp":1779134400000,"preClose":8.76,"halted":0,"volume":2105883,"hourTrading":{"tag":"盘后","latestPrice":8.49,"preClose":8.49,"latestTime":"16:10 EDT","volume":42441,"amount":360324.09,"timestamp":1779135004665,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.03082191780821913,"floatShares":124000000,"shares":150417084,"eps":-5.440705,"marketStatus":"Post-Mkt","change":-0.27,"latestTime":"05-18 17:50:01 EDT","open":8.74,"high":8.84,"low":8.43,"amount":18046491.213273,"amplitude":0.046804,"askPrice":9.4,"askSize":100,"bidPrice":8.53,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-5.440705,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1779148800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1493870400000,"exchange":"NYSE","adjPreClose":8.76,"preHourTrading":{"tag":"盘前","latestPrice":9.03,"preClose":8.76,"latestTime":"09:24 EDT","volume":1430,"amount":12577.923929999999,"timestamp":1779110667720,"change":0.27,"changeRate":0.030822,"amplitude":0.037671},"postHourTrading":{"tag":"盘后","latestPrice":8.49,"preClose":8.49,"latestTime":"16:10 EDT","volume":42441,"amount":360324.09,"timestamp":1779135004665,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.069283,"impliedVol":0.2266,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/BHVN/tweets","defaultTab":"tweets","newsList":[{"id":"2635100731","title":"Biohaven Is Maintained at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2635100731","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635100731?lang=en_us&edition=fundamental","pubTime":"2026-05-14 00:51","pubTimestamp":1778691060,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BHVN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 13, 2026 12:51 ET (16:51 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","LU1093756325.SGD","BK4139","BHVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635785433","title":"Morgan Stanley Cuts Price Target on Biohaven to $18 From $21, Keeps Overweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2635785433","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635785433?lang=en_us&edition=fundamental","pubTime":"2026-05-13 18:53","pubTimestamp":1778669597,"startTime":"0","endTime":"0","summary":"Biohaven (BHVN) has an average rating of overweight and mean price target of $22.19, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1093756325.SGD","BK4139","LU1093756168.USD","BHVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634243523","title":"Biohaven (BHVN) Valuation Check After Q1 Results And New Shelf Registration","url":"https://stock-news.laohu8.com/highlight/detail?id=2634243523","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634243523?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:48","pubTimestamp":1778586537,"startTime":"0","endTime":"0","summary":"Biohaven (BHVN) is back in focus after reporting first quarter results alongside filing an omnibus shelf registration, pairing a reduced net loss with fresh flexibility to issue a wide range of securities.\nSee our latest analysis for Biohaven.\nThose first quarter results and the new shelf registration arrive after a sharp reset, with the share price down 25.57% over 90 days and total shareholder return down 55.84% over one year. This points to fading momentum despite recent balance sheet...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bhvn/biohaven/news/biohaven-bhvn-valuation-check-after-q1-results-and-new-shelf","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bhvn/biohaven/news/biohaven-bhvn-valuation-check-after-q1-results-and-new-shelf","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BHVN","LU1093756168.USD","BK4139","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633906858","title":"Biohaven Warns of Broad Operational, Financial and Market Risks, Affirms Overall Risk Profile Matches Prior 10-K Disclosures","url":"https://stock-news.laohu8.com/highlight/detail?id=2633906858","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633906858?lang=en_us&edition=fundamental","pubTime":"2026-05-06 14:00","pubTimestamp":1778047214,"startTime":"0","endTime":"0","summary":"Biohaven Ltd. (BHVN) has disclosed a new risk, in the Regulation category. Biohaven Ltd. faces broad exposure to operational, financial, and market...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biohaven-warns-of-broad-operational-financial-and-market-risks-affirms-overall-risk-profile-matches-prior-10-k-disclosures?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biohaven-warns-of-broad-operational-financial-and-market-risks-affirms-overall-risk-profile-matches-prior-10-k-disclosures?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1093756325.SGD","BHVN","LU1093756168.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633392478","title":"Biohaven launches USD 350 million at-the-market share offering program","url":"https://stock-news.laohu8.com/highlight/detail?id=2633392478","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633392478?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:50","pubTimestamp":1778014220,"startTime":"0","endTime":"0","summary":"Biohaven entered Amendment No. 2 to its equity distribution agreement with J.P. Morgan Securities, setting up an at-the-market offering program for up to USD 350 million of common shares starting May 4, 2026.Sales, if any, may be executed on NYSE at prevailing market prices or via negotiated transactions, depending on market conditions, share price, capital needs.Program will be conducted off an effective shelf registration statement, supported by a base prospectus dated May 4, 2026 and a prospectus supplement dated May 4, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biohaven Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL4zsfX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","BHVN","LU1093756168.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116697967","title":"Stock Track | Biohaven Pharmaceutical Plummets 5.23% Intraday After Multiple Analyst Price Target Cuts","url":"https://stock-news.laohu8.com/highlight/detail?id=1116697967","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116697967?lang=en_us&edition=fundamental","pubTime":"2026-05-05 23:23","pubTimestamp":1777994600,"startTime":"0","endTime":"0","summary":"Biohaven Pharmaceutical Holding Co Ltd. (BHVN) saw its stock price plummet 5.23% during Tuesday's intraday trading session following negative analyst actions.The decline came after BofA Securities...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["BHVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633447917","title":"RBC Cuts Price Target on Biohaven to $22 From $23, Keeps Outperform, Speculative Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2633447917","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633447917?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:45","pubTimestamp":1777981523,"startTime":"0","endTime":"0","summary":"Biohaven (BHVN) has an average rating of overweight and mean price target of $22.60, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BHVN","LU1093756168.USD","LU1093756325.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633150739","title":"Biohaven price target lowered to $12 from $14 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2633150739","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633150739?lang=en_us&edition=fundamental","pubTime":"2026-05-05 17:56","pubTimestamp":1777975000,"startTime":"0","endTime":"0","summary":"BofA lowered the firm’s price target on Biohaven (BHVN) to $12 from $14 and keeps a Neutral rating on the shares. The firm views the company’s Q1 r...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biohaven-price-target-lowered-to-12-from-14-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biohaven-price-target-lowered-to-12-from-14-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BHVN","LU1093756168.USD","BK4139","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633961653","title":"Biohaven Ltd Files for Offering of up to $350 Mln Common Shares  - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2633961653","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633961653?lang=en_us&edition=fundamental","pubTime":"2026-05-05 05:09","pubTimestamp":1777928968,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nFWN41H0YS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1093756168.USD","LU1093756325.SGD","BK4139","BHVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633670969","title":"Biohaven files automatic mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2633670969","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633670969?lang=en_us&edition=fundamental","pubTime":"2026-05-05 04:38","pubTimestamp":1777927091,"startTime":"0","endTime":"0","summary":"16:27 EDT Biohaven (BHVN) files automatic mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving break...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biohaven-files-automatic-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biohaven-files-automatic-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BHVN","LU1093756325.SGD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633661329","title":"Biohaven Q1 Adj. EPS $(0.69) Beats $(0.78) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2633661329","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633661329?lang=en_us&edition=fundamental","pubTime":"2026-05-05 04:26","pubTimestamp":1777926419,"startTime":"0","endTime":"0","summary":"Biohaven Q1 Adj. EPS $(0.69) Beats $(0.78) Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/BHVN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Biohaven Q1 Adj. EPS $(0.69) Beats $(0.78) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","BHVN","LU1093756168.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633966923","title":"BRIEF-Biohaven Ltd Files For Mixed Shelf Offering Size Not Disclosed - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2633966923","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633966923?lang=en_us&edition=fundamental","pubTime":"2026-05-05 04:25","pubTimestamp":1777926343,"startTime":"0","endTime":"0","summary":"BRIEF-Biohaven Ltd Files For Mixed Shelf Offering Size Not Disclosed - SEC FilingMay 4  - Biohaven Ltd BHVN.N:BIOHAVEN LTD FILES FOR MIXED SHELF OFFERING; SIZE NOT DISCLOSED - SEC FILINGSource text: [ID:n0001628280-26-029834]Further company coverage: BHVN.N ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nFWN41H0YI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","LU1093756325.SGD","BHVN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633996374","title":"Biohaven Q1 FY26 net loss narrows to $130.53 million; R&D expense drops 44.67% to $103.83 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633996374","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633996374?lang=en_us&edition=fundamental","pubTime":"2026-05-05 04:05","pubTimestamp":1777925114,"startTime":"0","endTime":"0","summary":"Biohaven posted a Q1 net loss of USD 130.5 million, narrowing from USD 221.7 million a year earlier; loss per share improved to USD 0.88 from USD 2.17.R&D expense fell 44.7% to USD 103.8 million, while G&A expense dropped 21.8% to USD 26.6 million.Cash, cash equivalents, marketable securities and restricted cash totaled about USD 351.8 million as of March 31.Company expects to start pivotal trials by mid-year for BHV-1300 in Graves’ disease and BHV-1400 in IgA nephropathy, with epilepsy topline data and obesity topline results targeted for 2H 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDL828DPr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","LU1093756325.SGD","BK4139","BHVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633963462","title":"Biohaven holds annual shareholder meeting, elects directors to board","url":"https://stock-news.laohu8.com/highlight/detail?id=2633963462","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633963462?lang=en_us&edition=fundamental","pubTime":"2026-05-05 04:04","pubTimestamp":1777925097,"startTime":"0","endTime":"0","summary":"Biohaven held its annual shareholder meeting on April 28, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biohaven Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 04, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDLbhqD8z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHVN","BK4139","LU1093756325.SGD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633966117","title":"Biohaven Ltd - Q1 Non-Gaap Adj Net Loss $102.2 Mln, or $0.69 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2633966117","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633966117?lang=en_us&edition=fundamental","pubTime":"2026-05-05 04:02","pubTimestamp":1777924920,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nTUABHD03P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BHVN","BK4139","LU1093756325.SGD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633596311","title":"Biohaven Reports Recent Business Developments and First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633596311","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633596311?lang=en_us&edition=fundamental","pubTime":"2026-05-05 04:02","pubTimestamp":1777924920,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nTUABHD03P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1093756325.SGD","BHVN","BK4139","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632600178","title":"Assessing Biohaven (BHVN) Valuation After Prolonged Share Price Weakness And Elevated P/B Ratio","url":"https://stock-news.laohu8.com/highlight/detail?id=2632600178","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632600178?lang=en_us&edition=fundamental","pubTime":"2026-05-03 21:27","pubTimestamp":1777814873,"startTime":"0","endTime":"0","summary":"Recent share performance and business profile\nBiohaven (BHVN) has drawn investor attention after a period of weaker share returns, including an 18% decline over the past 3 months and a 57.86% drop over the past year.\nThe company focuses on developing treatments across immunology, neuroscience, and oncology, with multiple drug candidates in Phase 2 and Phase 3 clinical trials. It has a market capitalization of about US$1.45b.\nSee our latest analysis for Biohaven.\nAt a share price of US$9.63,...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bhvn/biohaven/news/assessing-biohaven-bhvn-valuation-after-prolonged-share-pric","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bhvn/biohaven/news/assessing-biohaven-bhvn-valuation-after-prolonged-share-pric","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1093756325.SGD","BK4139","BHVN","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629000606","title":"Assessing Biohaven (BHVN) Valuation After Sharp One Month Rebound And Steep One Year Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2629000606","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629000606?lang=en_us&edition=fundamental","pubTime":"2026-04-23 14:08","pubTimestamp":1776924494,"startTime":"0","endTime":"0","summary":"Recent performance snapshot\nBiohaven (BHVN) has recently caught investor attention after a one-month return of 22.2%, contrasting with a past three-month total return decline of 22.4% and a one-year total return decline of 50.1%.\nSee our latest analysis for Biohaven.\nThe recent 22.2% one month share price return, alongside a 4.8% one day gain at a share price of US$10.68, contrasts with a 50.1% one year total shareholder return decline. This suggests short term momentum after a tougher period...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bhvn/biohaven/news/assessing-biohaven-bhvn-valuation-after-sharp-one-month-rebo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bhvn/biohaven/news/assessing-biohaven-bhvn-valuation-after-sharp-one-month-rebo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1093756168.USD","LU1093756325.SGD","BK4139","BHVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624684261","title":"Why Biohaven (BHVN) Is Up 11.7% After Fully Enrolling Its Phase 2 Obesity Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2624684261","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624684261?lang=en_us&edition=fundamental","pubTime":"2026-04-03 03:26","pubTimestamp":1775157968,"startTime":"0","endTime":"0","summary":"Biohaven announced that it has completed enrollment in a U.S. Phase 2 proof-of-concept trial of taldefgrobep alfa, a myostatin-activin pathway inhibitor being tested as a self-administered obesity treatment, with topline data expected in the second half of 2026.\nAn unusual aspect of taldefgrobep alfa is its prior clinical profile, where participants showed meaningful fat loss alongside gains in lean muscle mass, hinting at a differentiated approach to weight management.\nWith Biohaven’s...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bhvn/biohaven/news/why-biohaven-bhvn-is-up-117-after-fully-enrolling-its-phase","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bhvn/biohaven/news/why-biohaven-bhvn-is-up-117-after-fully-enrolling-its-phase","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BHVN","BK4139","LU1093756325.SGD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624568827","title":"Biohaven Is Maintained at Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2624568827","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624568827?lang=en_us&edition=fundamental","pubTime":"2026-04-02 23:41","pubTimestamp":1775144460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BHVN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 02, 2026 11:41 ET (15:41 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","LU1093756325.SGD","BK4139","BHVN"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biohaven.com","stockEarnings":[{"period":"1week","weight":-0.1116},{"period":"1month","weight":-0.1553},{"period":"3month","weight":-0.2289},{"period":"6month","weight":0.0554},{"period":"1year","weight":-0.4463},{"period":"ytd","weight":-0.2241}],"compareEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":0.056},{"period":"3month","weight":0.0842},{"period":"6month","weight":0.1001},{"period":"1year","weight":0.2519},{"period":"ytd","weight":0.084}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Biohaven Ltd., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with debilitating neurological and neuropsychiatric diseases in the United States. The company's pipeline products include BHV-7000, a potassium channel activator for the treatment of focal epilepsy; BHV-7010, a Kv7 channel modulator for the treatment of different neurological diseases; Troriluzole, a tripeptide prodrug that is in Phase 3 clinical trial for the treatment of neurological and neuropsychiatric illnesses; BHV-5500, a low-trapping glutamate N-methyl-D-aspartate receptor antagonist for neuropathic pain; and Verdiperstat, an oral myeloperoxidase inhibitor, which is in Phase 3 clinical trial for the treatment of neurodegenerative diseases. It also offers Taldefgrobep Alfa, an anti-myostatin adnectin, which is in Phase 3 clinical trial for the treatment of spinal muscle atrophy; and BHV-1100 that is in Phase 1a/1b clinical trial for multiple myeloma patients. The company was formerly known as Biohaven Research Ltd and changed its name to Biohaven Ltd. in September 2022. Biohaven Ltd. was incorporated in 2022 and is headquartered in New Haven, Connecticut. Biohaven Ltd. is a subsidiary of Biohaven Pharmaceutical Holding Company Ltd.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.071849},{"month":2,"riseRate":0.222222,"avgChangeRate":-0.026101},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.120539},{"month":4,"riseRate":0.555556,"avgChangeRate":0.027819},{"month":5,"riseRate":0.555556,"avgChangeRate":0.118509},{"month":6,"riseRate":0.555556,"avgChangeRate":0.056007},{"month":7,"riseRate":0.555556,"avgChangeRate":0.010799},{"month":8,"riseRate":0.666667,"avgChangeRate":0.043364},{"month":9,"riseRate":0.777778,"avgChangeRate":0.09598},{"month":10,"riseRate":0.555556,"avgChangeRate":-0.072057},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.042561},{"month":12,"riseRate":0.555556,"avgChangeRate":0.054983}],"exchange":"NYSE","name":"Biohaven Pharmaceutical Holding Co Ltd.","nameEN":"Biohaven Pharmaceutical Holding Co Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biohaven Pharmaceutical Holding Co Ltd.(BHVN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Biohaven Pharmaceutical Holding Co Ltd.(BHVN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Biohaven Pharmaceutical Holding Co Ltd.,BHVN,Biohaven Pharmaceutical Holding Co Ltd.股票,Biohaven Pharmaceutical Holding Co Ltd.股票老虎,Biohaven Pharmaceutical Holding Co Ltd.股票老虎国际,Biohaven Pharmaceutical Holding Co Ltd.行情,Biohaven Pharmaceutical Holding Co Ltd.股票行情,Biohaven Pharmaceutical Holding Co Ltd.股价,Biohaven Pharmaceutical Holding Co Ltd.股市,Biohaven Pharmaceutical Holding Co Ltd.股票价格,Biohaven Pharmaceutical Holding Co Ltd.股票交易,Biohaven Pharmaceutical Holding Co Ltd.股票购买,Biohaven Pharmaceutical Holding Co Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biohaven Pharmaceutical Holding Co Ltd.(BHVN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Biohaven Pharmaceutical Holding Co Ltd.(BHVN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}